Salinosporamide A is a β-lactone proteasome inhibitor currently in clinical trials for the treatment of multiple-myeloma. Herein we report a short synthesis of this small, highly functionalized, biologically important natural product that uses an oxidative radical cyclization as a key step and allows for the preparation of gram quantities of advanced synthetic intermediates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/chem.201800046 | DOI Listing |
Publication Analysis
Top Keywords
total synthesis
4
synthesis salinosporamide a
4
salinosporamide a salinosporamide a
4
salinosporamide a β-lactone
4
β-lactone proteasome
4
proteasome inhibitor
4
inhibitor currently
4
currently clinical
4
clinical trials
4
trials treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!